Royal Brompton Hospital & Imperial College, London, UK.
Int J Cardiol. 2012 Nov 1;161(1):31-8. doi: 10.1016/j.ijcard.2011.04.023. Epub 2011 Jul 1.
Most percutaneous recanalizations of coronary artery chronic total occlusion (CTO) are not attempted because of the skepticism on their long-term clinical benefit. We assessed the effect of percutaneous CTO recanalization procedures on long-term cardiac survival, freedom from MACE and angina-related quality of life (AQL).
All consecutive patients who underwent attempt of percutaneous native coronary artery CTO recanalization between 2003 and 2009 were included in the study. MACE was defined as combined cardiac death, myocardial infarction (MI) and target vessel revascularization (TVR). AQL was assessed by the Seattle Angina Questionnaire-UK-version (SAQ-UK).
Among 302 patients who received an attempt of percutaneous CTO recanalization, 237 (78%) had a successful procedure while in 65 (22%) the procedure failed. Overall intra-hospital complication rate was 3.0%, with no difference between the two groups. Median follow-up was 4.0 years, during which 13 patients had a fatal cardiac event. Patients in whom the CTO recanalization procedure failed had a higher risk of cardiac death (HR 3.39; 95% CI 1.14-10.1;p=0.03; after propensity score adjustment, HR 2.83; 95% CI 0.89-8.96;p=0.07) and MACE (HR 5.40; 95% CI 2.71-10.5;p<0.001; adjusted HR 3.34; 95% CI 1.47-7.58;p=0.003) compared to patients with successful procedure. CTO recanalization significantly improved the AQL during follow-up: patients with successful procedure experienced less physical activity limitation (p=0.01), rarer angina episodes (p<0.001) and greater treatment satisfaction (p=0.03) compared to patients with failed procedure.
Patients with successful CTO recanalization had a trend towards better cardiac survival and significant lower risk of MACE and improvement of AQL compared to patients with failed procedures.
由于对经皮冠状动脉慢性完全闭塞(CTO)再通的长期临床获益存在怀疑,大多数此类再通操作都未进行尝试。我们评估了经皮 CTO 再通术对长期心脏生存率、无重大心脏不良事件(MACE)和与心绞痛相关的生活质量(AQL)的影响。
本研究纳入了 2003 年至 2009 年间接受经皮原生冠状动脉 CTO 再通术尝试的所有连续患者。MACE 定义为心脏死亡、心肌梗死(MI)和靶血管血运重建(TVR)的联合发生。AQL 通过西雅图心绞痛问卷-UK 版(SAQ-UK)进行评估。
302 例接受经皮 CTO 再通术尝试的患者中,237 例(78%)手术成功,65 例(22%)手术失败。整体院内并发症发生率为 3.0%,两组间无差异。中位随访时间为 4.0 年,期间有 13 例患者发生致死性心脏事件。CTO 再通术失败的患者发生心脏死亡的风险更高(HR 3.39;95%CI 1.14-10.1;p=0.03;经倾向评分调整后,HR 2.83;95%CI 0.89-8.96;p=0.07)和 MACE(HR 5.40;95%CI 2.71-10.5;p<0.001;调整 HR 3.34;95%CI 1.47-7.58;p=0.003)的风险更高。与手术成功的患者相比,CTO 再通显著改善了随访期间的 AQL:手术成功的患者经历更少的体力活动受限(p=0.01)、更少的心绞痛发作(p<0.001)和更高的治疗满意度(p=0.03)。
与手术失败的患者相比,成功进行 CTO 再通的患者具有更好的心脏生存率趋势,且 MACE 风险显著降低,AQL 得到显著改善。